Galecto, Inc.

The momentum for this stock is not very good. Galecto, Inc. is not a good value stock. Galecto, Inc. is not very popular among insiders. Galecto, Inc. is a mediocre stock to choose.

News

Galecto trading halted, news pending

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Galecto Announces Reverse Stock Split

Globe Newswire BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today...\n more…

GLTO Stock Earnings: Galecto Beats EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nGLTO stock results show that Galecto beat analyst estimates for earnings per share the second quarter of 2024.\nThe post GLTO Stock...\n more…

Galecto, Inc. (NASDAQ:GLTO) Sees Significant Increase in Short Interest

Ticker Report Galecto, Inc. (NASDAQ:GLTO - Get Free Report) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 30,800 shares, an increase of 1,084.6...\n more…

Galecto (NASDAQ:GLTO) vs. Generex Biotechnology (OTCMKTS:GNBT) Financial Contrast

Zolmax Galecto (NASDAQ:GLTO - Get Free Report) and Generex Biotechnology (OTCMKTS:GNBT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two...\n more…

Galecto (NASDAQ:GLTO) versus Generex Biotechnology (OTCMKTS:GNBT) Critical Analysis

Ticker Report Galecto (NASDAQ:GLTO - Get Free Report) and Generex Biotechnology (OTCMKTS:GNBT - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two...\n more…